<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Mechanism-based Inactivators </title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="bootstrap-superhero.css">
    <link rel="stylesheet" href="style.css">
    <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js" integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js" integrity="sha384-UO2eT0CpHqdSJQ6hJty5KVphtPhzWj9WO1clHTMGa3JDZwrnQq4sF86dIHNDz0W1" crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js" integrity="sha384-JjSmVgyd0p3pXB1rRibZUAYoIIy6OrQ6VrjIEaFf/nJGzIxFDsf4x0xIM+B07jRM" crossorigin="anonymous"></script>
</head>
<body>
  <nav class="navbar navbar-inverse">
    <div class="container-fluid">
      <div class="navbar-header">
        <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-2">
          <span class="sr-only">Toggle navigation</span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
        </button>
        <a class="navbar-brand" href="bonus-index.html">Home</a>
      </div>
  
      <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-2">
        <ul class="nav navbar-nav">
          <li class="active"><a href="https://www.linkedin.com/in/wei-chester-zhu-84b336109/" target="_blank">LinkedIn<span class="sr-only">(current)</span></a></li>
          <li><a href="https://scholar.google.com/citations?view_op=list_works&hl=en&user=qj8pqxEAAAAJ&gmla=AJsN-F69QaBARR4vy3Duy9U_MeS0wj7i1UsNiJWxCVf_zm7TuRVTzUeiPLaALc6SFt7LSnJpJo9J0vV8Nfjv-_4IJO479-0srI15F4MRxqfKLuvcBV3_iQZk3voBcS5XDuipMGrB7E-R" target="_blank">Google Scholar</a></li>
          <li><a href="https://github.com/wzhu0815" target="_blank">GitHub</a></li>
          <li class="dropdown">
            <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Research <span class="caret"></span></a>
            <ul class="dropdown-menu" role="menu">
              <li><a href="mbi.html">Mechanism-based Inactivators</a></li>
              <li class="divider"></li>
              <li><a href="ki.html">Kinase Inhibitors</a></li>
              <li class="divider"></li>
              <li><a href="ch.html">C-H Activation Methodology</a></li>
              
            </ul>
          </li>
        </ul>
        <ul class="nav navbar-nav navbar-right">
          <li><a href="mailto:wei.zhu@northwestern.com">Email Me</a></li>
        </ul>
      </div>
    </div>
  </nav>

    <div class="container">
        <div class="row">
          <div class="col-md-7">
              <h2 class="cadetblue">Mechanism-based Inactivators</h2>
              <hr>
              <a href="https://pubs.acs.org/doi/abs/10.1021/jacs.0c00193" target="_blank"><img src="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jacsat/2020/jacsat.2020.142.issue-10/jacs.0c00193/20200304/images/medium/ja0c00193_0012.gif" alt="Mechanism-based Inactivators" ></a>
            <div class="row">
              <div class="col-md">
                <p>Human ornithine aminotransferase (hOAT), a pyridoxal 5â€²-phosphate-dependent enzyme, plays a critical role in the progression of hepatocellular carcinoma (HCC). Pharmacological selective inhibition of hOAT has been shown to be a potential therapeutic approach for HCC. Inspired by the discovery of the nonselective aminotransferase inactivator (1R,3S,4S)-3-amino-4-fluoro cyclopentane-1-carboxylic acid (1), in this work, we rationally designed, synthesized, and evaluated a novel series of fluorine-substituted cyclohexene analogues, thereby identifying 8 and 9 as novel selective hOAT time-dependent inhibitors. Intact protein mass spectrometry and protein crystallography demonstrated 8 and 9 as covalent inhibitors of hOAT, which exhibit two distinct inactivation mechanisms resulting from the difference of a single fluorine atom. Interestingly, they share a similar turnover mechanism, according to the mass spectrometry-based analysis of metabolites and fluoride ion release experiments. Molecular dynamics (MD) simulations and electrostatic potential (ESP) charge calculations were conducted, which elucidated the significant influence of the one-fluorine difference on the corresponding intermediates, leading to two totally different inactivation pathways. The novel addition-aromatization inactivation mechanism for 9 contributes to its significantly enhanced potency, along with excellent selectivity over other aminotransferases.</p>
                <a href="https://pubs.acs.org/doi/abs/10.1021/jacs.0c00193" target="_blank">J. Am. Chem. Soc. 2020, 142, 4892-4903. </a>
                <hr>
                <h5>Other Related Publications:</h5>
                <ol>
                    <li><a href="https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00672" target="_blank"> <p class = 'justify'> Shen, S.; Doubleday, P. F.; Weerawarna, P. M.; Zhu, W.; Kelleher, N. L.; Silverman, R. B., Mechanism-Based Design of 3-Amino-4-Halocyclopentenecarboxylic Acids as Inactivators of GABA Aminotransferase. Acs. Med. Chem. Lett. 2020.</p></a></li>
                </ol>
              </div>
            </div>
          </div>
          <div class="col-md-1"></div>
          <div class="col-md-4">
            <h2 class="cadetblue">Research</h2>
            <hr>
              <h5><a href="mbi.html">Mechanism-based Inactivators</a></h5>
                <hr> 
                  <h5><a href="ki.html">Kinase Inhibitors</a></h5>
                <hr>
              <h5><a href="ch.html">C-H Activation Methodology</a></h5>
                <hr>
          </div>
  
    </div>
    </div>
</body>

</html>